A popular GLP-1 provider just made its weight loss medications cheaper

Mochi Health just lowered the cost of its compounded GLP-1 medications while adding a new lab-testing service designed to help patients track key health markers during treatment.

The telehealth platform recently announced a new dose-based pricing structure for compounded semaglutide and compounded tirzepatide, along with the launch of Mochi Labs, an integrated blood-testing service.

For people exploring GLP-1 weight-loss treatment, the updates address two common concerns: affordability and ongoing medical monitoring.

Under Mochi Health's new pricing model, compounded semaglutide now starts at $60 per month, while compounded tirzepatide starts at $90 per month.

The company says pricing is now tied to dosage levels, which could benefit many new patients who begin treatment on lower introductory doses before gradually increasing over time.

According to Mochi Health, no dose costs more than previous pricing, and many options are now available at lower monthly rates.

Patients who enroll begin with a live, 30-minute virtual appointment with a licensed healthcare provider before receiving any prescription recommendation. Membership plans start at $39 for the first month and include unlimited provider visits, direct messaging and access to healthcare professionals. Medication costs are separate from membership fees.

Alongside the pricing change, Mochi Health launched Mochi Labs, a…

Original source: https://www.usatoday.com/life/